Nishanian P, Taylor J M, Korns E, Detels R, Saah A, Fahey J L
J Clin Microbiol. 1987 Feb;25(2):395-400. doi: 10.1128/jcm.25.2.395-400.1987.
The characteristics of primary (first) tests with three enzyme-linked immunosorbent assay (ELISA) kits for human immunodeficiency virus (HIV) antibody were determined. The three ELISAs were performed on 3,229, 3,130, and 685 specimens from high-risk individuals using the Litton (LT; Litton Bionetics Laboratory Products, Charleston, S.C.), Dupont (DP; E. I. du Pont de Nemours & Co., Inc., Wilmington, Del.), and Genetic Systems (GS; Genetic Systems, Seattle, Wash.) kits, respectively. Evaluation was based on the distribution of quantitative test results (such as optical densities), a comparison with Western blot (WB) results, reproducibility of the tests, and identification of seroconverters. The performances of the GS and the DP kits were good by all four criteria and exceeded that of the LT kit. Primary ELISA-negative results were not always confirmed with repeat ELISA and by WB testing. The largest percentage of these unconfirmed negative test results came from samples with quantitative results in the fifth percentile nearest the cutoff. Thus, supplementary testing was indicated for samples with test results in this borderline negative range. Similarly, borderline positive primary ELISA results that were quantitatively nearest (fifth percentile) the cutoff value were more likely to be antibody negative on supplementary testing than samples with high antibody values. In this study, results of repeated tests by GS ELISA showed the least change from first test results. DP ELISA showed more unconfirmed primary positive test results, and LT ELISA showed more unconfirmed primary negative test results. Designation of a specimen with a single ELISA quantitative level near the cutoff value as positive or negative should be viewed with skepticism. A higher than normal proportion of specimens with high negative optical densities by GS ELISA (fifth percentile nearest the cutoff) and also negative by WB were found to be from individuals in the process of seroconversion.
测定了三种用于人类免疫缺陷病毒(HIV)抗体检测的酶联免疫吸附测定(ELISA)试剂盒进行初次(首次)检测的特性。分别使用利顿(LT;利顿生物工程实验室产品公司,南卡罗来纳州查尔斯顿)、杜邦(DP;E.I.杜邦公司,特拉华州威尔明顿)和基因系统(GS;基因系统公司,华盛顿州西雅图)试剂盒,对来自高危个体的3229份、3130份和685份标本进行了这三种ELISA检测。评估基于定量检测结果(如光密度)的分布、与免疫印迹(WB)结果的比较、检测的可重复性以及血清转化者的识别。根据所有这四项标准,GS和DP试剂盒的性能良好,超过了LT试剂盒。初次ELISA阴性结果并非总是通过重复ELISA和WB检测得到确认。这些未确认的阴性检测结果中,最大比例来自定量结果处于最接近临界值的第五百分位数的样本。因此,对于检测结果处于这个临界阴性范围的样本,需要进行补充检测。同样,定量上最接近(第五百分位数)临界值的临界阳性初次ELISA结果,在补充检测时比抗体值高的样本更有可能为抗体阴性。在本研究中,GS ELISA重复检测的结果与首次检测结果相比变化最小。DP ELISA显示有更多未确认的初次阳性检测结果,而LT ELISA显示有更多未确认的初次阴性检测结果。对于定量水平接近临界值的单一ELISA检测结果的标本判定为阳性或阴性应持怀疑态度。发现通过GS ELISA(最接近临界值的第五百分位数)光密度高且WB检测为阴性的标本比例高于正常水平,这些标本来自正在进行血清转化的个体。